Exploring Liraglutide’s mechanism in reducing renal fibrosis: the Fsp1-CoQ10-NAD(P)H pathway
Abstract Studies have confirmed that elevated glucose levels could lead to renal fibrosis through the process of ferroptosis. Liraglutide, a human glucagon-like peptide-1 (GLP-1) analogue, is a potential treatment option for diabetes. This study aimed to examine the potential of liraglutide (LIRA) i...
Saved in:
| Main Authors: | Qi Chen, Ji-Xian Song, Zhi Zhang, Ji-Ren An, Yu-Jing Gou, Miao Tan, Yashuo Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-85658-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FSP1 and CoQ10 have the potential to serve as biomarkers for severe preeclampsia
by: Peishan LI, et al.
Published: (2025-08-01) -
Aberrant DNA hypermethylation-regulated long non-coding RNA RYR3-DT affects ferroptosis and progression of glioma cell through the CoQ10/FSP1 axis
by: Yang Cui
Published: (2025-07-01) -
A CoQ10 analog ameliorates cognitive impairment and early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation
by: Junhui Chen, et al.
Published: (2025-07-01) -
The Spectrum of clinical manifestations in newborns with the COQ4 mutation: case series and literature review
by: Pianpian Pan, et al.
Published: (2024-09-01) -
Protective role of CoQ10 in reducing the side effects resulting from the use of Tramadol on some immunological variables in the endemic female rabbits
by: Hanan Shihab Ahmad Hussain, et al.
Published: (2023-02-01)